Format

Send to

Choose Destination
Arthritis Res Ther. 2006;8 Suppl 2:S3. Epub 2006 Jul 28.

Interleukin-6 and chronic inflammation.

Author information

1
Division of Rheumatology, University Hospital of Geneva, Switzerland. cem.gabay@hcuge.ch

Abstract

Interleukin (IL)-6 is produced at the site of inflammation and plays a key role in the acute phase response as defined by a variety of clinical and biological features such as the production of acute phase proteins. IL-6 in combination with its soluble receptor sIL-6Ralpha, dictates the transition from acute to chonic inflammation by changing the nature of leucocyte infiltrate (from polymorphonuclear neutrophils to monocyte/macrophages). In addition, IL-6 exerts stimulatory effects on T- and B-cells, thus favoring chronic inflammatory responses. Strategies targeting IL-6 and IL-6 signaling led to effective prevention and treatment of models of rheumatoid arthritis and other chronic inflammatory diseases.

PMID:
16899107
PMCID:
PMC3226076
DOI:
10.1186/ar1917
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for BioMed Central Icon for PubMed Central
Loading ...
Support Center